STAT3 and hepatocellular carcinoma: To explore the underlying molecular mechanisms driving the synergistic antitumor effects, we detected the expression levels of drug‐treated HCC cell STAT3 phosphorylation, which was reported to be aberrantly activated in HCC [23, 24].